Скачать или смотреть Advancing GLP-1 Peptide Analysis: Chromatography Challenges and LC–MS Solutions

GLP-1 peptide drugs such as semaglutide and tirzepatide are transforming diabetes and obesity treatment—and pushing chromatographers to solve new analytical challenges.

In this episode of Concentrating on Chromatography, produced in collaboration with Separation Science, Sean Orlewitz, Principal Marketing Development Manager at Phenomenex, discusses the separation, quantitation, and quality control of therapeutic peptides. He shares practical insights on:

✅ Overcoming challenges in GLP-1 peptide analysis and impurity profiling
✅ Optimizing LC column selectivity and efficiency for peptide separations
✅ Building robust and transferable analytical methods across global labs
✅ The expanding role of high-resolution mass spectrometry (HRMS) in QC and R&D
✅ Using size-exclusion chromatography (SEC) for aggregation testing in sterile injectables

Sean also explores how Phenomenex is supporting scientists with new ARIS Peptide XB-C18 and size-exclusion columns, as well as technical papers and educational webinars designed to help labs adopt peptide workflows with confidence.

Whether you’re developing new GLP-1 analogs or troubleshooting complex peptide methods, this conversation delivers real-world advice for improving selectivity, reproducibility, and data quality in peptide chromatography.

📘 Watch now to learn how advanced LC–MS solutions are shaping the future of peptide analysis.

🔗 Explore more expert insights at sepscience.com

#Chromatography #LCMS #PeptideAnalysis #GLP1 #Phenomenex #MassSpectrometry #Semaglutide #Tirzepatide #PharmaAnalysis #SeparationScience